Eli Lilly and Co (WBO:LLYC) Other Operating Expense : €-0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Eli Lilly and Co Other Operating Expense?

Eli Lilly and Co's Other Operating Expense for the three months ended in Dec. 2023 was €-0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-0 Mil.

Eli Lilly and Co's quarterly Other Operating Expense declined from Jun. 2023 (€-0 Mil) to Sep. 2023 (€-0 Mil) but then increased from Sep. 2023 (€-0 Mil) to Dec. 2023 (€-0 Mil).

Eli Lilly and Co's annual Other Operating Expense increased from Dec. 2021 (€-0 Mil) to Dec. 2022 (€-0 Mil) but then declined from Dec. 2022 (€-0 Mil) to Dec. 2023 (€-0 Mil).

Eli Lilly and Co Other Operating Expense Historical Data

The historical data trend for Eli Lilly and Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Other Operating Expense Chart

Eli Lilly and Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

Eli Lilly and Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Eli Lilly and Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0 Mil.

Eli Lilly and Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Eli Lilly and Co (WBO:LLYC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (WBO:LLYC) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

LLY:USA LLY:Mexico 1LLY:Italy LLY:Germany LLY:Switzerland LLY:Canada LILY34:Brazil LLY:Argentina

Address

Lilly Corporate Center, Indianapolis, IN, USA, 46285

Website

https://www.lilly.com

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Eli Lilly and Co (WBO:LLYC) Headlines

No Headlines